Home Infusion

Full support for infusion – at home.

The Challenge

The infusion market is growing at an annual rate of 15 percent1; in many cases, these medications are difficult to manage because of complex shipping requirements or specialized administration needs.  Patients must make trips to infusion centers or inpatient facilities to get the treatment they need:  approximately 75 percent2 of infusions take place outside of the home.

  • The home infusion therapy market is expected to grow 64% in the next three years and reach $27B by 20203

  • 34-42% of new specialty drugs in the pipeline are infused4

The CareCentrix Approach

CareCentrix provides nursing, drugs, and the administration of supplies and functions to support infusion therapy in the home or Ambulatory Infusion Suite (AIS).

The CareCentrix Home Infusion approach:

  • Identifies and recommends targeted drugs that may be appropriate to transition from higher cost settings to home
  • Optimizes provider networks based on specific drug therapies
  • Collects and monitors provider data to determine how patients are responding to therapy

Benefits

  • Cost reduction

    • Reduces the unnecessary costs of outpatient infusion services by directing care home when possible, using a full-support approach
  • Risk reduction

    • Reduces the risks associated with unmanaged home infusion
  • Network management

    • Provides access to over 1,000 home and ambulatory infusion pharmacies and nursing agencies helping ensure immediate infusion needs and faster hospital discharge
  • Coordination of infusion services

    • Offers programs for patients on complex or specialty medications, such as Immune Deficiencies or Hemophilia

Need help managing Home Infusion?

Sources:

  1. National Association of Independent Retail Druggists (NAIRD) in Association with National Home Infusion Association (NHIA)
  2. Shelley, Suzanne. “Home-Infusion Providers Struggle With Unfriendly Reimbursement Policies.” October 2009
  3. Persistence Market Research (PMR), “Home Infusion Therapy Market Will Reach USD 26.7 billion in 2020.” May 2015
  4. http://www.ahdbonline.com/issues/2010/january-february-2010-vol-3-no-1/97-feature-97